Australia's most trusted
source of pharma news
Wednesday, 02 July 2025
Posted 26 June 2025 PM
Counterfeits of Novo Nordisk’s popular semaglutide-containing medicines and Roche’s discontinued laroscrobine have been seized by the Australian Border Force (ABF).
In a safety advisory update, the TGA said that examples of counterfeit Rybelsus-labelled products have been stopped at the Australian border. Rybelsus is currently TGA approved for the treatment of type 2 diabetes.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.